Aflibercept – Longer Lasting, Higher Dose to Optimize Treatment
Time: 9:30 am
day: Conference Day 2
Details:
- Translating learnings from the aflibercept 8 mg program to improve treatment delivery and sustain disease control when treating Wet AMD, DME and DR
- Addressing the potential risks and side effects when developing higher dose formulation
